Q&A With Robert Lisak from Wayne State University School of Medicine: New Research and Treatments Highlight CMSC Agenda

It was a busy few days in Indianapolis for the Consortium of Multiple Sclerosis Centers. The annual meeting highlighted not only new treatments currently available to patients but also work coming down the pipeline for future options.

It was a busy few days in Indianapolis for the Consortium of Multiple Sclerosis Centers. The annual meeting highlighted not only new treatments currently available to patients but also work coming down the pipeline for future options.

Robert P. Lisak, MD, from the Wayne State University School of Medicine said advancements in the treatment of the relapsing form of the condition, and new research about the progressive form made for an informative session. Lisak, who also serves as President of the Consortium of Multiple Sclerosis Centers said he was also encouraged to see many new attendees at the event and the contributions made by first time people at the annual conference.